Literature DB >> 6739680

Depression in hospitalized cancer patients.

J Bukberg, D Penman, J C Holland.   

Abstract

The study of depression in cancer patients has been hampered by difficulty in establishing diagnostic criteria, since neurovegetative signs and symptoms may be attributable either to depression or physical illness. Confusion has also arisen in defining the boundary between "normal" grieving with illness, and "abnormal" clinical depression. We studied 62 oncology inpatients applying DSM-III diagnostic criteria, patient self-report, and interview report rating scales. Forty-two percent met criteria for nonbipolar major depression: 24% with severe and 18% with moderately severe symptoms. Fourteen percent of the sample had depressive symptoms that did not meet criteria for a major depression. Forty-four percent had no depressed affect. Medical and demographic variables were evaluated for relationship to depression; only greater degree of physical disability was clearly associated. Other negative life events and poor quality of social supports were additionally associated with depression in the less disabled patients. The use of clearly defined criteria for diagnosis of depression in cancer patients provides a basis for the study and implementation of specific therapeutic interventions.

Entities:  

Mesh:

Year:  1984        PMID: 6739680     DOI: 10.1097/00006842-198405000-00002

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  55 in total

Review 1.  Towards a new conceptualization of depression in older adult cancer patients: a review of the literature.

Authors:  Rebecca M Saracino; Barry Rosenfeld; Christian J Nelson
Journal:  Aging Ment Health       Date:  2015-08-27       Impact factor: 3.658

2.  Depression and cancer mortality and morbidity: prospective evidence from the Alameda County study.

Authors:  G A Kaplan; P Reynolds
Journal:  J Behav Med       Date:  1988-02

3.  Chemotherapy drug thioTEPA exacerbates stress-induced anhedonia and corticosteroid responses but not impairment of hippocampal cell proliferation in adult mice.

Authors:  Courtney L Wilson; E Todd Weber
Journal:  Behav Brain Res       Date:  2012-09-04       Impact factor: 3.332

4.  Performance of four diagnostic approaches to depression in adults with cancer.

Authors:  Rebecca M Saracino; Barry Rosenfeld; Christian J Nelson
Journal:  Gen Hosp Psychiatry       Date:  2018-01-31       Impact factor: 3.238

5.  Depressive symptom patterns and their consequences for diagnosis of affective disorders in cancer patients.

Authors:  Katrin Reuter; Simone Raugust; Jürgen Bengel; Martin Härter
Journal:  Support Care Cancer       Date:  2004-10-09       Impact factor: 3.603

6.  Diabetes burden and diabetes distress: the buffering effect of social support.

Authors:  Rachel N Baek; Molly L Tanenbaum; Jeffrey S Gonzalez
Journal:  Ann Behav Med       Date:  2014-10

7.  Antidepressant prescribing in community cancer care.

Authors:  Fredrick D Ashbury; Lisa Madlensky; Peter Raich; Mark Thompson; Geoff Whitney; Ken Hotz; Boris Kralj; William S Edell
Journal:  Support Care Cancer       Date:  2003-03-06       Impact factor: 3.603

Review 8.  Identifying patients at risk for, and treatment of major psychiatric complications of cancer.

Authors:  W Breitbart
Journal:  Support Care Cancer       Date:  1995-01       Impact factor: 3.603

9.  Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure.

Authors:  Wei Jiang; Christopher O'Connor; Susan G Silva; Maragatha Kuchibhatla; Michael S Cuffe; Dwayne D Callwood; Bosh Zakhary; Elizabeth Henke; Rebekka M Arias; Ranga Krishnan
Journal:  Am Heart J       Date:  2008-07-07       Impact factor: 4.749

Review 10.  A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer.

Authors:  Martin R Chasen; Ravi Bhargava
Journal:  Support Care Cancer       Date:  2009-07-18       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.